Single vs. Dual Blood Thinners After Balloon Heart Treatment
Treatments studied
Part of Heart & circulation clinical trials.
This study compares whether patients who receive a special drug-coated balloon to open a blocked heart artery (without a stent) need to take one or two blood-thinning medications afterward. The goal is to find the safest and most effective approach for preventing future blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had a successful heart procedure using a drug-coated balloon (without a stent) to open a blocked artery
- Age 18 or older
- The blocked artery is medium-sized (between 2.0 and 4.5 mm wide)
- No more than 2 blocked areas treated, in no more than 2 different arteries
- Stable condition within 24 hours after the procedure (no heart attack, stroke, or new blockages)
- Willing to take blood-thinning medications as assigned and follow up with the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two kinds of drug-coated balloons used during angioplasty to open narrowed heart arteries in people with acute coronary syndrome. Both balloons slowly release medicine to help keep the artery open, and the trial aims to see if one works better than the other.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This study tests whether a shorter period of dual blood-thinning therapy (two medicines) is as safe and effective as the standard longer period after a drug-coated balloon procedure for blocked heart arteries. You may join if you've already had the procedure and have been stable for a month.
This trial compares taking a single blood thinner (aspirin) for 1 month versus 6 months after a special balloon treatment (called a drug-coated balloon, or DCB) to open a blocked heart artery. The goal is to see if the shorter course is just as safe and effective, meaning some people might avoid the risks of longer blood-thinner use.
This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
Hear when a new Coronary Heart Disease (CHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.